Somatostatin

This classification denotes a hypothalmic hormone, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6E20216Q0L. European Medicines Agency schedules Somatostatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12320MIG. Somatostatin generally arises in the molecular formula C76H104N18O19S2. The term SOMATOSTATIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, no. 10 1980, list 20.) SOMATOSTATIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule somatostatin under HS 29371900 and SITC 54154. As of Q4 2014, SOMATOSTATIN remains the US FDA Preferred Term for this commodity. Somatostatin bears US NLM identifiers UMLS ID C0037659 and NCI Concept Code C28418. SMILES: S1SCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(N)C)C1)CCCCN)CC(=O)N)CC1CCCCC1)CC1CCCCC1)CC1C2C([NH]C1)CCCC2)CCCCN)C(O)C)CC1CCCCC1)C(O)C)CO)C(=O)O.